Nicolaas I Bohnen

Author PubWeight™ 41.85‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. J Nucl Med 2013 1.93
2 Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association. Alzheimers Dement 2013 1.87
3 β-Amyloid and postural instability and gait difficulty in Parkinson's disease at risk for dementia. Mov Disord 2012 1.69
4 Modifiable cardiovascular risk factors and axial motor impairments in Parkinson disease. Neurology 2014 1.59
5 Altered resting state cortico-striatal connectivity in mild to moderate stage Parkinson's disease. Front Syst Neurosci 2010 1.41
6 Symptoms of rapid eye movement sleep behavior disorder are associated with cholinergic denervation in Parkinson disease. Ann Neurol 2012 1.14
7 Thalamic cholinergic innervation and postural sensory integration function in Parkinson's disease. Brain 2013 1.12
8 Brain PET in suspected dementia: patterns of altered FDG metabolism. Radiographics 2014 1.05
9 Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia. Neurology 2012 1.04
10 Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's disease. J Neurophysiol 2009 1.04
11 In vivo imaging of human cholinergic nerve terminals with (-)-5-(18)F-fluoroethoxybenzovesamicol: biodistribution, dosimetry, and tracer kinetic analyses. J Nucl Med 2014 1.04
12 Spared caudal brainstem SERT binding in early Parkinson's disease. J Cereb Blood Flow Metab 2007 1.02
13 Cholinergic denervation occurs early in Parkinson disease. Neurology 2009 0.98
14 Diabetes is associated with postural instability and gait difficulty in Parkinson disease. Parkinsonism Relat Disord 2013 0.96
15 Cerebral small vessel disease and incident parkinsonism: the RUN DMC study. Neurology 2016 0.96
16 Cholinergic dysfunction in Parkinson's disease. Curr Neurol Neurosci Rep 2013 0.95
17 Striatal dopamine denervation and sensory integration for balance in middle-aged and older adults. Gait Posture 2006 0.94
18 Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. J Nucl Med 2013 0.89
19 Gender differences in nigrostriatal dopaminergic innervation are present at young-to-middle but not at older age in normal adults. J Clin Neurosci 2011 0.87
20 Rhinorrhea: a common nondopaminergic feature of Parkinson's disease. Mov Disord 2010 0.85
21 Update on appropriate use criteria for amyloid PET imaging: dementia experts, mild cognitive impairment, and education. Amyloid Imaging Task Force of the Alzheimer’s Association and Society for Nuclear Medicine and Molecular Imaging. Alzheimers Dement 2013 0.85
22 Dopamine overdose hypothesis: evidence and clinical implications. Mov Disord 2013 0.85
23 Clinical markers for identifying cholinergic deficits in Parkinson's disease. Mov Disord 2014 0.84
24 l-DOPA changes ventral striatum recruitment during motor sequence learning in Parkinson's disease. Behav Brain Res 2012 0.84
25 Insomnia and sleepiness in Parkinson disease: associations with symptoms and comorbidities. J Clin Sleep Med 2013 0.84
26 FDG-PET and molecular brain imaging in the movement disorders clinic. Neurology 2012 0.82
27 Cognitive correlates of brain MRI subcortical signal hyperintensities in non-demented elderly. Int J Geriatr Psychiatry 2006 0.82
28 Gender differences in cholinergic and dopaminergic deficits in Parkinson disease. J Neural Transm (Vienna) 2013 0.82
29 Olfactory loss and nigrostriatal dopaminergic denervation in the elderly. Neurosci Lett 2010 0.81
30 Thalamic cholinergic innervation is spared in Alzheimer disease compared to parkinsonian disorders. Neurosci Lett 2012 0.81
31 The pattern of striatal dopaminergic denervation explains sensorimotor synchronization accuracy in Parkinson's disease. Behav Brain Res 2013 0.81
32 Performance on an Alzheimer-selective odor identification test in patients with Parkinson's disease and its relationship with cerebral dopamine transporter activity. Parkinsonism Relat Disord 2009 0.80
33 The role of serotonin in sleep disordered breathing associated with Parkinson disease: a correlative [11C]DASB PET imaging study. PLoS One 2012 0.80
34 Source memory and frontal functioning in Parkinson's disease. J Int Neuropsychol Soc 2009 0.80
35 Single case study of brain FDG PET imaging in a patient with catatonia. Clin Nucl Med 2013 0.80
36 Pattern of cardiac sympathetic denervation in idiopathic Parkinson disease studied with 11C hydroxyephedrine PET. Radiology 2012 0.79
37 Age-related striatal dopaminergic denervation and severity of a slip perturbation. J Gerontol A Biol Sci Med Sci 2011 0.78
38 Advanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease. J Gerontol A Biol Sci Med Sci 2014 0.78
39 Cerebral amyloid deposition and serotoninergic innervation in Parkinson disease. Arch Neurol 2012 0.78
40 An update on brain imaging in parkinsonian dementia. Imaging Med 2012 0.77
41 Effects of donepezil on compulsive hypersexual behavior in Parkinson disease: a single case study. Am J Ther 2005 0.76
42 Author response. Neurology 2014 0.75
43 Can PET imaging tell us what's the matter with the gray matter in multiple sclerosis? Neurology 2012 0.75
44 Clinical features of Parkinson disease when onset of diabetes came first: a case-control study. Neurology 2012 0.75
45 2014 SNMMI Highlights Lecture: Neuroscience. J Nucl Med 2014 0.75
46 Autoimmune limbic encephalitis detected on FDG brain scan performed for the evaluation of dementia. Clin Nucl Med 2015 0.75
47 A frontotemporal dementia-like syndrome mimicking postpartum depression detected by 18F fluorodeoxyglucose positron emission tomography. Clin Nucl Med 2012 0.75